This finding is in concordance with current literature on breast cancers from individuals heterozygous for CHEK2 PVs (9,10) and indicates that HRD does not seem to be driving the process of tumorigenesis in CHEK2-deficient cancers. The gene discussed is CHEK2; the disease is breast cancer.